Aspiriant LLC’s Aetna Inc AET Stock Holding History

Aspiriant LLC’s Portfolio AET Stock Details AET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,928	Closed	-$246K	–	204
2016 Q2	$246K	Buy	+1,928	New	+$221K	0.02%	167

Other funds holding AET

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Aspiriant LLC's AET Position: Q3 2016 in Review

Aspiriant LLC sold out of Aetna Inc (AET) in Q3 2016, closing a stake of 1,928 shares — an estimated $246K sold.

Aspiriant LLC first reported a position in AET in Q2 2016 and held it in 1 quarter. The position peaked at $246K in Q2 2016. 800 funds tracked by Wall St. Rank hold AET as of Q3 2016.

Aspiriant LLC reported no remaining Aetna Inc position as of Q3 2016 after selling out during the quarter.
Aspiriant LLC sold 1,928 Aetna Inc shares in Q3 2016, an estimated $246K.
Aspiriant LLC first reported a position in Aetna Inc in Q2 2016 and held it in 1 quarter.
Aspiriant LLC's Aetna Inc position peaked at $246K in Q2 2016.
800 funds tracked by Wall St. Rank held Aetna Inc as of Q3 2016.

Based on Aspiriant LLC's 13F filing for Q3 2016, filed 10 Nov 2016.